Skip to main content

Year: 2021

Invitation to presentation of Copperstone Resources Q3 report 2021

Kiruna September 15, 2021 Copperstone Resources’ interim report for January – September 2021 will be published on Friday, November 19, 2021 at 07:30 CET. A live presentation for analysts, media and investors will be held the same day at 09:30 CET. The report is presented by CEO Anna Tyni and by acting chairman Jörgen Olsson. The presentation will be held in Swedish and also includes a question and answer session. Date: Friday, November 19th Time: The report is published at 07:30 and the live presentation starts at 09:30 CET. The live presentation can be accessed via the link below: https://www.youtube.com/watch?v=nVFatFmTepc The interim report, the presentation and a recorded version of the presentation will also be available on the company’s website: https://copperstone.se/sv/ For further information, please contact...

Continue reading

Condor Gold plc announces its unaudited results for the three and nine months ended 30 September, 2021

LONDON, Nov. 15, 2021 (GLOBE NEWSWIRE) — Condor Gold (AIM: CNR; TSX: COG) announces that it has today published its unaudited financial results for the three and nine months ending 30 September, 2021 and the Management’s Discussion and Analysis for the same period. Both of the above have been posted on the Company’s website www.condorgold.com and are also available on SEDAR at www.sedar.com . Highlights for the third quarter of 2021Completion of 3,370 m of diamond core infill drilling and replacement of RC drilling within and around the La India Starter Pits, which are within the fully permitted La India Open Pit. Infill drilling was to 25 m by 25 m drill spacing. Highlight drill assay results:22.05 m (21.6 m true width) at 6.48 g/t gold from 24.75 m drill depth including 15.35 m (15.0 m true width) at 8.68 g/t gold from 24.75...

Continue reading

KBC Group: KBC acquires Bulgarian operations of Raiffeisen Bank International

Press Release Outside trading hours – Regulated information* Brussels, Sofia, 15 November 2021 (7.45 a.m. CET) KBC acquires Bulgarian operations of Raiffeisen Bank International This morning, Belgium-based KBC Bank (‘KBC’) and Austria-based Raiffeisen Bank International (‘RBI’) reached an agreement for KBC to acquire 100% of the shares of Raiffeisenbank (Bulgaria) EAD, comprising RBI’s Bulgarian banking operations. The transaction also includes Raiffeisenbank Bulgaria’s fully-owned subsidiaries Raiffeisen Leasing Bulgaria, Raiffeisen Asset Management (Bulgaria), Raiffeisen Insurance Broker (serving Raiffeisenbank Bulgaria’s leasing and corporate clients) and Raiffeisen Service. The deal, involving a total consideration of 1 015 million euros paid in cash, reflects the quality of the Raiffeisen franchise and the synergies potential....

Continue reading

HEINEKEN intends to acquire control of Distell and Namibia Breweries to create a regional beverage champion for Southern Africa

HEINEKEN intends to acquire control of Distell and NBL, which will be combined with HEINEKEN South Africa into a new HEINEKEN majority owned business with a total valuation of approximately €4 billion Distell is Africa’s leading producer and marketer of ciders, flavoured alcoholic beverages, wines and spirits, and NBL is the beer market leader in Namibia Better able to serve consumers and customers with a unique multi-category portfolio, led by iconic brands Heineken®, Savanna, Windhoek, 4th Street wine and Amarula Combination will have a significantly strengthened and complementary route to market in South Africa and Namibia with further growth opportunities across Southern Africa EPS accretion expected within one year and operating profit margin accretion over the medium term on realisation of significant synergiesAmsterdam,...

Continue reading

Boskalis receives EUR 450 million offshore wind project

Bokalift 1 in actionBoskalis Bokalift 1 in actionPapendrecht, 15 November 2021 Boskalis has been awarded a contract for the transportation and installation of the monopile foundations and substations for an offshore wind farm development with a value of approximately EUR 450 million. Boskalis’ successful track record in offshore wind energy is founded in Europe and has expanded to Asia in recent years and more recently to the US East Coast. Boskalis’ unique offering of marine transport and installation capabilities through its state-of-the-art Bokalift 1 and Bokalift 2 crane vessels and versatile heavy transport fleet are ideally suited for large-scale offshore wind projects. This contract ties-up one year of crane vessel utilization days in addition to the equivalent of two years of heavy transport vessels. Engineering...

Continue reading

OSE Immunotherapeutics Presented the First Positive Preclinical Efficacy Data on CLEC-1, a Novel Myeloid Immune Checkpoint Target For Cancer Immunotherapy

Data presented at the 36th Annual Society for Immunotherapy of Cancer (SITC) Meeting NANTES, France, Nov. 15, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)  presented the first positive preclinical efficacy data on its novel myeloid cell immune checkpoint target, CLEC-1 (a C-type lectin receptor), at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting in Washington D.C. held in-person and virtually on November 10 – 14, 2021. In the poster entitled: “Preclinical efficacy of CLEC-1 antagonist as novel myeloid immune checkpoint therapy for oncology”, OSE Immunotherapeutics and Dr Elise Chiffoleau’s research team* reported results from their collaborative program, and for the first time highlighted significant preclinical efficacy of CLEC-1 antagonist antibodies in vivo and in monotherapy...

Continue reading

U.S. Generator Sales Market to Hit USD 6.94 Billion by 2028 Backed by Increasing Development of Industrial Infrastructures, reports Fortune Business Insights™

Companies Profiled in U.S. Generator Market Are Generac Power Systems, American Honda Motor Corp., Caterpillar Inc., Cummins Inc., Ingersoll Rand, John Deere, Briggs and Stratton, HiPower Systems, Kohler – SDMO, Wacker Neuson Pune, India, Nov. 15, 2021 (GLOBE NEWSWIRE) — The U.S. generator sales market size is expected to showcase exponential growth by reaching USD 6.94 billion by 2028. Fortune Business Insights in its report titled, “U.S. Sales Market, 2021-2028.”, mentions that the market stood at USD 4.68 billion in 2020 and is projected to exhibit a CAGR of 5.13% between 2021 and 2028.  Factors such as the rising oilfield activities and the increasing focus on development of infrastructure in the U.S. is likely to boost the product’s demand during the foreseeable future. COVID-19 has resulted in several economies facing unprecedented...

Continue reading

Teck Named Industry Leader on 2021 Dow Jones Sustainability World Index

VANCOUVER, British Columbia, Nov. 14, 2021 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) has been named to the S&P Dow Jones Sustainability World Index (DJSI) for the 12th consecutive year and is ranked #1 in the Metals and Mining industry category on the DJSI for 2021.   “We recognize that sustainability is foundational to our success and being socially and environmentally responsible is core to how we operate as a company,” said Don Lindsay, President and CEO. “This commitment is led by our people, who are dedicated to providing essential resources while caring for communities and the environment.” The DJSI ranking indicates that Teck’s sustainability practices are in the top 10 percent of the 2,500 largest companies in the S&P Global Broad Market Index (BMI). Teck is a leader...

Continue reading

Late Breaking Presentation at American Heart Association Annual Meeting of Landmark Phase 3 Trial of Rexlemestrocel-L in Chronic Heart Failure

Trial Results Highlighted Reduction in Cardiovascular Mortality, Heart Attacks and Strokes, with Greatest Effect Seen in Setting of Inflammation NEW YORK, Nov. 14, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that results from the randomized, controlled Phase 3 trial of rexlemestrocel-L in 565 patients with New York Heart Association (NYHA) class II and class III chronic heart failure (CHF) with reduced ejection fraction (HFrEF) were presented as a late breaking presentation at the American Heart Association (AHA) annual Scientific Sessions during a featured program titled ‘Building on the Foundations of Treatment: Advances in Heart Failure Therapy’. The trial’s co-principal investigator Dr. Emerson Perin, Medical Director...

Continue reading

89bio Presents New Data from Phase 1b/2a NASH Study Showing BIO89-100 Reduces Spleen Volume 

New sub-analysis presented at The Liver Meeting® 2021 shows treatment with BIO89-100 reduced spleen volume by an average of 11.8% in NASH patients Oral presentation was highlighted by the AASLD Scientific Program Committee as a key presentation in The Liver Meeting® 2021 SAN FRANCISCO, Nov. 14, 2021 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the presentation of new data from a post-hoc analysis of the Phase 1b/2a proof-of-concept study evaluating BIO89-100 in patients with nonalcoholic steatohepatitis (NASH) at The Liver Meeting® 2021 of the American Association for the Study of Liver Diseases (AASLD). The sub-analysis, which assessed the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.